Cargando…
Fragment-based inhibitor design for SARS-CoV2 main protease
COVID-19 disease caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV2) has resulted in tremendous loss of lives across the world and is continuing to do so. Extensive work is under progress to develop inhibitors which can prevent the disease by arresting the virus in its life cycle....
Autores principales: | Andola, Priyanka, Pagag, Jishu, Laxman, Durgam, Guruprasad, Lalitha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9251026/ https://www.ncbi.nlm.nih.gov/pubmed/35811782 http://dx.doi.org/10.1007/s11224-022-01995-z |
Ejemplares similares
-
Discovery of inhibitors against SARS-CoV-2 main protease using fragment-based drug design
por: Shao, Hai Ping, et al.
Publicado: (2023) -
Crystallographic and electrophilic fragment screening of the SARS-CoV-2 main protease
por: Douangamath, Alice, et al.
Publicado: (2020) -
Computational fragment screening of dimeric SARS-CoV-2 main protease
por: Reid, Rashad L., et al.
Publicado: (2023) -
Potential SARS-CoV-2 main protease inhibitors
por: Banerjee, Riddhidev, et al.
Publicado: (2021) -
Developing inhibitors of the SARS-CoV-2 main protease
por: Seitz, Christian, et al.
Publicado: (2022)